A collaborative study published on January 21 in Nature Communications presents a novel strategy to improve the effectiveness ...

Among adults with relapsed or refractory indolent B-cell non-Hodgkin lymphoma, the phase 2 TRANSCEND FL trial met its primary ...

A collaborative study, published on January 21 on Nature Communications, presents a novel strategy to improve the ...

CIRBP Family, Tumors, Molecular Mechanisms, RNA-Binding Proteins, Cellular Stress Share and Cite: Cai, Y. , Wang, T. and Zhan ...

Flu continues to be one of the most common and alarming seasonal illnesses. In the period spanning from 2023 to 2024, there ...